The USPTO issues two different responses to an application. First, the patent is “allowed” which was the March release. Today’s announcement is the official “issuance” of the patent. Thus, we made the reference to the patent as “originally allowed in March 2012” in the first paragraph.
LAKE OSWEGO, Ore., July 18, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced the issuance of a key patent, originally allowed in March 2012, from the U.S. Patent and Trademark Office